Targeting the MEK1/2 pathway to combat Staphylococcus aureus infection and inflammation in cystic fibrosis

ABSTRACT Staphylococcus aureus infections remain an ongoing challenge for people with cystic fibrosis (PwCF), with the increased global prevalence of multidrug-resistant strains requiring new therapeutic approaches. Our previous studies demonstrated anti-inflammatory effects of several MEK1/2 inhibi...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Eryn Zuiker, Gregory Serpa, Mithu De, Yiwei Liu, Daniel J. Wozniak, Kymberly M. Gowdy, Jean Charron, Susan E. Birket, Megan R. Kiedrowski, Emily A. Hemann, Matthew E. Long
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology 2025-07-01
Saila:	mBio
Gaiak:	Staphylococcus aureus cystic fibrosis macrophages MEK1/2
Sarrera elektronikoa:	https://journals.asm.org/doi/10.1128/mbio.00775-25
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!